Loading...
| A10538 | Pages: 241 | Jul 2021 | 1376 Views | | |
| Author(s) : Smita Nerkar , Onkar Sumant | Tables: 153 | Charts: 46 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bronchoscopy Market
Request Now !The global bronchoscopy market size was valued at $2,558.21 million in 2020, and is projected to reach $4,880.72 million by 2030, registering a CAGR of 6.30% from 2021 to 2030.
Bronchoscopy is the most common interventional pulmonology procedures performed through the bronchoscope. Bronchoscopy can be performed through reusable bronchoscopes or single use bronchoscopes. Single use bronchoscope or reusable bronchoscope both are intended for use during endoscopic examination, diagnosis, and treatment of airways and tracheobronchial tree. The conditions such as COPD, tumors, lung cancer, airway stenosis, pneumonia, bronchitis, and other lung infections can be diagnosed through single use bronchoscope.
Get more information on this report : Request Sample Pages
Factors such as increase in number of cases related to respiratory diseases, developments related to products improving reimbursement policies, and technological advancements will further drive the market growth. For instance, according to the World Health Organization (WHO), in 2018, around 2.09 million cases of lung cancer were reported. Furthermore, this might increase the demand for minimally invasive procedures; thereby, boosting the bronchoscope market growth. However, risk of contamination of devices may hinder the growth of the bronchoscope market. Conversely, growth opportunities in emerging markets are anticipated to provide opportunities for market.
The outbreak of COVID-19 has disrupted workflows in the health care sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. However, there has also been a negative effect and surge in demand for various medical services, including bronchoscopy products such as visualization & documentation systems and endoscope.
Bronchoscopy is an aerosol-generating procedure with important diagnostic and therapeutic indications. However, in the era of the coronavirus disease 2019 (COVID-19) pandemic, airway procedures can put health care providers at an increased risk of exposure and transmission of COVID-19. Various societies of respiratory medicine to stratify the indications for bronchoscopy and optimize pre procedural, procedural, and post procedural preparation. Furthermore, appropriate measures can help decrease exposure to health care workers when performing this aerosol-generating procedure.
Bronchoscopy remains one of the highest risk procedures within this population of patients due to its detectible disruption of airway mucosa and the increased pressures utilized to oxygenate and ventilate patients during the procedure. Secondary to the close contact between the medical personnel involved in the bronchoscopy and the patient, coughing and suction can produce significant amounts of droplets or aerosols, contaminating indoor equipment, procedure room’s air, all personnel present, and even resulting in a higher risk of patient-to-patient cross-infection. Nevertheless, bronchoscopy remains an imperative and important method for the diagnosis and treatment of respiratory illnesses that in certain instances cannot be postponed pending further progression of disease and clinical deterioration. Therefore, it is critical to stratify the patients requiring prompt bronchoscopy intervention along with those patients who may benefit from a delayed procedure.
The global bronchoscopy market is segmented on the basis of product, usability, application, end user, and region. On the basis of product, the market is categorized into endoscope, visualization and documentation systems, accessories, and other products. By usability, it is classified into disposable equipment and reusable equipment. On the basis of application, it is segmented into bronchial diagnosis and bronchial treatment. Furthermore, by end user it classified into hospitals and ambulatory surgical centers & clinics. The hospitals segment is further classified into disposable equipment and reusable equipment. Moreover, ambulatory surgical centers & clinics segment is subdivided into disposable equipment and reusable equipment. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product, the endoscopes segment accounted for the largest share of the bronchoscopy market in 2020. The large share of this segment can be attributed to be the high cost of bronchoscopes compared to the imaging systems and accessories, increasing prevalence of lung cancer, and technological advancements.
Get more information on this report : Request Sample Pages
On the basis of end user, the bronchoscopy market is segmented into hospitals and ambulatory surgery centers (ASCs)/clinics. Hospitals commanded the largest share of the bronchoscopy market in 2020. The large share of this end-user segment can be attributed to be the high patient preference for hospital-based treatment & procedures, availability of skilled healthcare professionals, technologically advanced facilities, and favorable reimbursement scenario.
Get more information on this report : Request Sample Pages
North America dominated the bronchoscopy market in 2020. The large share of North America in the global bronchoscopy market is attributed to increase the incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the U.S., and rise in incidence of lung cancer in Canada. On the other hand, Asia-Pacific is projected to register the highest growth during the forecast period, owing to factors such as increase in number of hospitals, developing healthcare infrastructure, surge in healthcare expenditure, growth in geriatric population, and the presence of a large patient population.
Get more information on this report : Request Sample Pages
The key bronchoscopy market players profiled in the report include Olympus Corporation, Karl Storz, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Medtronic, Johnson & Johnson, Hoyo Corporation, Richard Wolf GmbH, and Cook Medical
Key Benefits For Stakeholders
Key Market Segments
By Product
By Usability
By End User
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rising prevalence of respiratory diseases
3.5.1.2.Growing demand for minimally invasive surgery
3.5.1.3.Technological advancements in bronchoscopy
3.5.2.Restraints
3.5.2.1.Dearth of trained physicians and pulmonologists
3.5.3.Opportunity
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on Bronchoscopy market
CHAPTER 4:BRONCHOSCOPY MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Endoscope
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Visualization and documentation systems
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Accessories
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Other Products
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
CHAPTER 5:BRONCHOSCOPY MARKET, BY USABILITY
5.1.Overview
5.1.1.Market size and forecast
5.2.Disposable equipment
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Reusable equipment
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
CHAPTER 6:BRONCHOSCOPY MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Bronchial diagnosis
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Bronchial treatment
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
CHAPTER 7:BRONCHOSCOPY MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospitals
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.2.3.Market size and forecast, by usability
7.2.3.1.Disposable Equipment
7.2.3.1.1.Market size and forecast
7.2.3.2.Reusable Equipment
7.2.3.2.1.Market size and forecast
7.3.Ambulatory surgical centers & clinics
7.3.1.Market size and forecast
7.3.2.Market analysis, by country
7.3.3.Market size and forecast, by usability
7.3.3.1.Disposable Equipment
7.3.3.1.1.Market size and forecast
7.3.3.2.Reusable Equipment
7.3.3.2.1.Market size and forecast
CHAPTER 8:BRONCHOSCOPY MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S. Bronchoscopy market, by product
8.2.2.2.U.S. Bronchoscopy market, by usability
8.2.2.3.U.S. Bronchoscopy market, by application
8.2.2.4.U.S. Bronchoscopy market, by end user
8.2.2.5.Canada Bronchoscopy market, by product
8.2.2.6.Canada Bronchoscopy market, by usability
8.2.2.7.Canada Bronchoscopy market, by application
8.2.2.8.Canada Bronchoscopy market, by end user
8.2.2.9.Mexico Bronchoscopy market, by product
8.2.2.10.Mexico Bronchoscopy market, by usability
8.2.2.11.Mexico Bronchoscopy market, by application
8.2.2.12.Mexico Bronchoscopy market, by end user
8.2.3.North America market size and forecast, by product
8.2.4.North America market size and forecast, by usability
8.2.5.North America market size and forecast, by application
8.2.6.North America Bronchoscopy market, by end user
8.2.6.1.North America hospital, by usability
8.2.6.2.North America ambulatory surgical centers and clinics, by usability
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany Bronchoscopy market, by product
8.3.2.2.Germany Bronchoscopy market, by usability
8.3.2.3.Germany Bronchoscopy market, by application
8.3.2.4.Germany Bronchoscopy market, by end user
8.3.2.5.France Bronchoscopy market, by product
8.3.2.6.France Bronchoscopy market, by usability
8.3.2.7.France Bronchoscopy market, by application
8.3.2.8.France Bronchoscopy market, by end user
8.3.2.9.UK Bronchoscopy market, by product
8.3.2.10.UK Bronchoscopy market, by usability
8.3.2.11.UK Bronchoscopy market, by application
8.3.2.12.UK Bronchoscopy market, by end user
8.3.2.13.Italy Bronchoscopy market, by product
8.3.2.14.Italy Bronchoscopy market, by usability
8.3.2.15.Italy Bronchoscopy market, by application
8.3.2.16.Italy Bronchoscopy market, by end user
8.3.2.17.Spain Bronchoscopy market, by product
8.3.2.18.Spain Bronchoscopy market, by usability
8.3.2.19.Spain Bronchoscopy market, by application
8.3.2.20.Spain Bronchoscopy market, by end user
8.3.2.21.Rest of Europe Bronchoscopy market, by product
8.3.2.22.Rest of Europe Bronchoscopy market, by usability
8.3.2.23.Rest of Europe Bronchoscopy market, by application
8.3.2.24.Rest of Europe Bronchoscopy market, by end user
8.3.3.Europe market size and forecast, by product
8.3.4.Europe market size and forecast, by usability
8.3.5.Europe market size and forecast, by application
8.3.6.Europe Bronchoscopy market, by end user
8.3.6.1.Europe hospital, by usability
8.3.6.2.Europe ambulatory surgical centers and clinics, by usability
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan Bronchoscopy market, by product
8.4.2.2.Japan Bronchoscopy market, by usability
8.4.2.3.Japan Bronchoscopy market, by application
8.4.2.4.Japan Bronchoscopy market, by end user
8.4.2.5.China Bronchoscopy market, by product
8.4.2.6.China Bronchoscopy market, by usability
8.4.2.7.China Bronchoscopy market, by application
8.4.2.8.China Bronchoscopy market, by end user
8.4.2.9.Australia Bronchoscopy market, by product
8.4.2.10.Australia Bronchoscopy market, by usability
8.4.2.11.Australia Bronchoscopy market, by application
8.4.2.12.Australia Bronchoscopy market, by end user
8.4.2.13.India Bronchoscopy market, by product
8.4.2.14.India Bronchoscopy market, by usability
8.4.2.15.India Bronchoscopy market, by application
8.4.2.16.India Bronchoscopy market, by end user
8.4.2.17.Rest of Asia-Pacific Bronchoscopy market, by product
8.4.2.18.Rest of Asia-Pacific Bronchoscopy market, by usability
8.4.2.19.Rest of Asia-Pacific Bronchoscopy market, by application
8.4.2.20.Rest of Asia-Pacific Bronchoscopy market, by end user
8.4.3.Asia-Pacific market size and forecast, by product
8.4.4.Asia-Pacific market size and forecast, by usability
8.4.5.Asia-Pacific market size and forecast, by application
8.4.6.Asia-Pacific Bronchoscopy market, by end user
8.4.6.1.Asia-Pacific hospital, by usability
8.4.6.2.Asia-Pacific ambulatory surgical centers and clinics, by usability
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil Bronchoscopy market, by product
8.5.2.2.Brazil Bronchoscopy market, by usability
8.5.2.3.Brazil Bronchoscopy market, by application
8.5.2.4.Brazil Bronchoscopy market, by end user
8.5.2.5.Saudi Arabia Bronchoscopy market, by product
8.5.2.6.Saudi Arabia Bronchoscopy market, by usability
8.5.2.7.Saudi Arabia Bronchoscopy market, by application
8.5.2.8.Saudi Arabia Bronchoscopy market, by end user
8.5.2.9.South Africa Bronchoscopy market, by product
8.5.2.10.South Africa Bronchoscopy market, by usability
8.5.2.11.South Africa Bronchoscopy market, by application
8.5.2.12.South Africa Bronchoscopy market, by end user
8.5.2.13.Rest of LAMEA Bronchoscopy market, by product
8.5.2.14.Rest of LAMEA Bronchoscopy market, by usability
8.5.2.15.Rest of LAMEA Bronchoscopy market, by application
8.5.2.16.Rest of LAMEA Bronchoscopy market, by end user
8.5.3.LAMEA market size and forecast, by product
8.5.4.LAMEA market size and forecast, by usability
8.5.5.LAMEA market size and forecast, by application
8.5.6.LAMEA Bronchoscopy market, by end user
8.5.6.1.LAMEA hospital, by usability
8.5.6.2.LAMEA ambulatory surgical centers and clinics, by usability
CHAPTER 9:COMPANY PROFILES
9.1.AMBU A/S
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.BOSTON SCIENTIFIC CORPORATION
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.COOK GROUP INCORPORATED
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments
9.4.JOHNSON & JOHNSON
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.FUJIFILM HOLDINGS CORPORATION
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.6.HOYA CORPORATION
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.KARL STORZ SE AND CO. KG
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Key strategic moves and developments
9.8.MEDTRONIC PLC. (COVIDIEN)
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.OLYMPUS CORPORATION
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.10.RICHARD WOLF GMBH
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030($MILLION )
TABLE 02.ENDOSCOPE BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 03.VISUALIZATION AND DOCUMENTATION SYSTEMS BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 04.ACCESSORIESBRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 05.OTHER PRODUCTS BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 06.BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030($MILLION )
TABLE 07.DISPOSABLE EQUIPMENT BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 08.REUSABLE EQUIPMENT BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 09.BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030($MILLION )
TABLE 10.BRONCHIAL DIAGNOSIS BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 11.BRONCHIAL TREATMENT BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 12.BRONCHOSCOPY MARKET, BY END USER, 2020–2030($MILLION )
TABLE 13.HOSPITALS BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 14.HOSPITAL, BY USABILITY, 2020–2030 ($BILLION)
TABLE 15.AMBULATORY SURGICAL CENTERS & CLINICS BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 16.AMBULATORY SURGICAL CENTERS AND CLINICS, BY USABILITY, 2020–2030 ($BILLION)
TABLE 17.BRONCHOSCOPY MARKET, BY REGION, 2020–2030($MILLION )
TABLE 18.NORTH AMERICA BRONCHOSCOPY MARKET, BY COUNTRY, 2020–2030($MILLION )
TABLE 19.U.S. BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 20.U.S. BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 21.U.S. BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 22.U.S. BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 23.CANADA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 24.CANADA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 25.CANADA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 26.CANADA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 27.MEXICO BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 28.MEXICO BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 29.MEXICO BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 30.MEXICO BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 31.NORTH AMERICA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 32.NORTH AMERICA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 33.NORTH AMERICA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 34.NORTH AMERICA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 35.NORTH AMERICA HOSPITAL, BY USABILITY, 2020-2030
TABLE 36.NORTH AMERICA AMBULATORY SURGICAL CENTERS AND CLINICS, BY USABILITY, 2020-2030
TABLE 37.EUROPE BRONCHOSCOPY MARKET, BY COUNTRY, 2020–2030($MILLION )
TABLE 38.GERMANY BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 39.GERMANY BRONCHOSCOPY, BY USABILITY, 2020–2030
TABLE 40.GERMANY BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 41.GERMANY BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 42.FRANCE BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 43.FRANCE BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 44.FRANCE BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 45.FRANCE BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 46.UK BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 47.UK BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 48.UK BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 49.UK BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 50.ITALY BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 51.ITALY BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 52.ITALY BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 53.ITALY BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 54.SPAIN BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 55.SPAIN BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 56.SPAIN BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 57.SPAIN BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 58.REST OF EUROPE BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 59.REST OF EUROPE BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 60.REST OF EUROPE BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 61.REST OF EUROPE BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 62.EUROPE BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 63.EUROPE BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 64.EUROPE BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 65.EUROPE BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 66.EUROPE HOSPITAL, BY USABILITY, 2020-2030
TABLE 67.EUROPE AMBULATORY SURGICAL CENTERS AND CLINICS, BY USABILITY, 2020-2030
TABLE 68.ASIA-PACIFIC BRONCHOSCOPY MARKET, BY COUNTRY, 2020–2030($MILLION )
TABLE 69.JAPAN BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 70.JAPAN BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 71.JAPAN BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 72.JAPAN BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 73.CHINA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 74.CHINA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 75.CHINA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 76.CHINA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 77.AUSTRALIA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 78.AUSTRALIA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 79.AUSTRALIA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 80.AUSTRALIA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 81.INDIA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 82.INDIA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 83.INDIA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 84.INDIA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 85.REST OF ASIA-PACIFIC BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 86.REST OF ASIA-PACIFIC BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 87.REST OF ASIA-PACIFIC BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 88.REST OF ASIA-PACIFIC BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 89.ASIA-PACIFIC BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 90.ASIA-PACIFIC BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 91.ASIA-PACIFIC BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 92.ASIA-PACIFIC BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 93.ASIA-PACIFIC HOSPITAL, BY USABILITY, 2020-2030
TABLE 94.ASIA-PACIFIC AMBULATORY SURGICAL CENTERS AND CLINICS, BY USABILITY, 2020-2030
TABLE 95.LAMEA BRONCHOSCOPY MARKET, BY COUNTRY, 2020–2030($MILLION )
TABLE 96.BRAZIL BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 97.BRAZIL BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 98.BRAZIL BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 99.BRAZIL BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 100.SAUDI ARABIA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 101.SAUDI ARABIA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 102.SAUDI ARABIA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 103.SAUDI ARABIA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 104.SOUTH AFRICA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 105.SOUTH AFRICA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 106.SOUTH AFRICA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 107.SOUTH AFRICA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 108.REST OF LAMEA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 109.REST OF LAMEA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 110.REST OF LAMEA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 111.REST OF LAMEA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 112.LAMEA BRONCHOSCOPY MARKET, BY PRODUCT, 2020–2030
TABLE 113.LAMEA BRONCHOSCOPY MARKET, BY USABILITY, 2020–2030
TABLE 114.LAMEA BRONCHOSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 115.LAMEA BRONCHOSCOPY MARKET, BY END USER, 2020–2030
TABLE 116.LAMEA HOSPITAL, BY USABILITY, 2020-2030
TABLE 117.LAMEA AMBULATORY SURGICAL CENTERS AND CLINICS, BY USABILITY, 2020-2030
TABLE 118.AMBU: COMPANY SNAPSHOT
TABLE 119.AMBU: OPERATING SEGMENTS
TABLE 120.AMBU: PRODUCT PORTFOLIO
TABLE 121.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 122.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 123.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 124.BOSTON SCIENTIFIC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125.COOK MEDICAL: COMPANY SNAPSHOT
TABLE 126.COOK MEDICAL: OPERATING BUSINESS SEGMENTS
TABLE 127.COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 128.COOK MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129.J&J: COMPANY SNAPSHOT
TABLE 130.J&J: OPERATING SEGMENTS
TABLE 131.J&J: PRODUCT PORTFOLIO
TABLE 132.J&J: KEY STRATIGIC MOVES AND DEVELOPMENTS
TABLE 133.FUJIFILM: COMPANY SNAPSHOT
TABLE 134.FUJIFILM: OPERATING BUSINESS SEGMENTS
TABLE 135.FUJIFILM: PRODUCT PORTFOLIO
TABLE 136.HOYA: COMPANY SNAPSHOT
TABLE 137.HOYA: OPERATING SEGMENTS
TABLE 138.HOYA: PRODUCT PORTFOLIO
TABLE 139.HOYA: KEY STRATIGIC MOVES AND DEVELOPMENTS
TABLE 140.KARL STROZ COMPANY SNAPSHOT
TABLE 141.KARL STROZ OPERATING SEGMENTS
TABLE 142.KARL STROZ: PRODUCT PORTFOLIO
TABLE 143.KARL STROZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144.MEDTRONIC: COMPANY SNAPSHOT
TABLE 145.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 146.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 147.OLYMPUS: COMPANY SNAPSHOT
TABLE 148.OLYMPUS: PRODUCT SEGMENTS
TABLE 149.OLYMPUS: PRODUCT PORTFOLIO
TABLE 150.RICHARD WOLF: COMPANY SNAPSHOT
TABLE 151.RICHARD WOLF: OPERATING SEGMENT
TABLE 152.RICHARD WOLF: PRODUCT PORTFOLIO
TABLE 153.RICHARD WOLF: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.BRONCHOSCOPY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF ENDOSCOPE BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 14.COMPARATIVE ANALYSIS OF VISUALIZATION AND DOCUMENTATION SYSTEMS BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 15.COMPARATIVE ANALYSIS OF ACCESSORIESBRONCHOSCOPY, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 16.COMPARATIVE ANALYSIS OF OTHER PRODUCTS BRONCHOSCOPY, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 17.COMPARATIVE ANALYSIS OF DISPOSABLE EQUIPMENT BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 18.COMPARATIVE ANALYSIS OF REUSABLE EQUIPMENT BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 19.COMPARATIVE ANALYSIS OF BRONCHIAL DIAGNOSIS BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 20.COMPARATIVE ANALYSIS OF BRONCHIAL TREATMENT BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 21.COMPARATIVE ANALYSIS OF HOSPITALS BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 22.DISPOSABLE EQUIPMENT MARKET, 2020–2030 ($MILLION)
FIGURE 23.REUSABLE EQUIPMENT MARKET, 2020–2030 ($BILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF AMBULATORY SURGICAL CENTERS & CLINICS BRONCHOSCOPY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION )
FIGURE 25.DISPOSABLE EQUIPMENT MARKET, 2020–2030 ($MILLION)
FIGURE 26.REUSABLE EQUIPMENT MARKET, 2020–2030 ($BILLION)
FIGURE 27.AMBU: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.AMBU: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 29.AMBU: REVENUE SHARE BY REGION, 2020(%)
FIGURE 30.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 33.J&J: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.J&J: REVENUE SHARE BY REGION, 2020(%)
FIGURE 36.FUJIFILM: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.FUJIFILM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.FUJIFILM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.HOYA: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.HOYA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.MEDTRONIC: NET SALES, 2018–2020 ($MILLION
FIGURE 42.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.OLYMPUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.OLYMPUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.OLYMPUS: REVENUE SHARE BY REGION, 2020(%)
The bronchoscopy market has witnessed significant growth due to increase in hospital investments in bronchoscopy facilities, rise in demand for bronchoscopy due to the increase in prevalence of respiratory diseases, surge in demand for minimally invasive surgery, and technological advancements in bronchoscopy. However, risk of contamination of devices may hinder the growth of the bronchoscope market and is among the major restraints to this market.
North America is expected to hold a major market share in the global bronchoscope market due to increase in number of bronchoscopy procedures and higher prevalence rates of respiratory diseases such as lung cancer. According to the American Cancer Society, approximately 228,820 new cases of lung cancer were recorded in 2020; thereby, driving the demand for bronchoscope devices. According to the National Centre of Biotechnology Information, around 500,000 procedures of bronchoscopy are performed in the U.S. every year. Hence, it is expected to boost the bronchoscope market growth.
A. The total market value of Bronchoscopy market is 2558.21 million in 2020.
A. The forcast period for Bronchoscopy market is 2021 to 2030
A. The market value of Bronchoscopy market in 2021 is $2816.59 million.
A. The base year is 2020 in Bronchoscopy market
A. Top companies such as Olympus Corporation, KARL STORZ, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific, Medtronic, Johson & Johnso, Hoyo Corporation, Richard Wolf GmbH and Cook Medical held a high market position in 2020.
A. Based on product, endoscopes segment accounted for the largest share of the bronchoscopy market in 2020. The large share of this segment can be attributed to the high cost of bronchoscopes compared to the imaging systems and accessories, increasing prevalence of lung cancer, and technological advancements.
A. Growing hospital investments in bronchoscopy facilities, rising demand for bronchoscopy owing to the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgery, and technological advancements in bronchoscopy will further propel the market growth. However, the dearth of trained physicians and pulmonologists may hinder the growth of bronchoscope market.
A. Bronchoscopes are primarily used for the assessment and management of multiple respiratory and airway diseases. Conditions such as blockages, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions can be detected and diagnosed through these devices.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
